Where do Vor Biopharma's ratios come from?

Every ratio is computed from Vor Biopharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Vor Biopharma VOR Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Liquidity
Current ratio	31.1×+27.3×	18.2×+13.0×	9.2×+4.5×	3.5×-3.1×	3.9×-4.6×
Quick ratio	31.1×+27.3×	18.2×+13.0×	9.2×+4.5×	3.5×-3.1×	3.9×-4.6×
Cash ratio	10.6×+7.6×	15.8×+11.3×	8.5×+4.8×	3.2×-2.3×	3×-0.4×
Leverage
Debt-to-assets	0×-0.3×	0×-0.2×	0×-0.3×	——	0.3×+0.1×
Per Share
Book value per share	-$3.50-133%	-$16.64+40.8%	-$333.07-1,663%	-$12.02-937%	$10.59+485%
Valuation
Market capitalization	$784.61M+2,513%	$286.59M+107%	$333.92M+598%	$39.75M-41.6%	$89.58M-44.3%
Enterprise value	$617.68M+5,639%	-$106.89M-221%	$176.52M+533%	——	$70.32M-53.3%
Free cash flow yield	-19.2%+316pp	-50.1%+22.1pp	-43.3%+166pp	-287%-133pp	-112.3%-45.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Vor Biopharma's ratios come from?: Every ratio is computed from Vor Biopharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.